In fact, only about 50% of ALT+ leiomyosarcomas and pleomorphic liposarcomas are also ATRX deficient [24, 25]; at the same time ALT+ appears to be highly correlated with ATRX loss in angiosarcomas and dedifferentiated liposarcomas [24, 43]. This evidence concerns the gene ATRX and liposarcoma.